Back to top

Top Ranked Value Stocks to Buy for March 5th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, March 5th:

DHI Group, Inc. : This provider of employment connections, data and insights via specialized services has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 16.7% over the last 60 days.

DHI has a price-to-earnings ratio (P/E) of 10.86, compared with 18.60 for the industry. The company possesses a Value Score of A.

Domtar Corporation (UFS - Free Report) : This manufacturer of specialty and packaging papers, absorbent hygiene products and communication papers etc has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 8.7% over the last 60 days.

Domtarhas a price-to-earnings ratio (P/E) of 9.39, compared with 14.50 for the industry. The company possesses a Value Score of A.

DXC Technology Company (DXC - Free Report) : This information technology services and solutions provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 1.1% over the last 60 days.

DXC Technology has a price-to-earnings ratio (P/E) of 8.09, compared with 13.40 for the industry. The company possesses a Value Score of A.

SYNNEX Corporation (SNX - Free Report) : This business process services provider has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 1.2% over the last 60 days.

SYNNEX has a price-to-earnings ratio (P/E) of 8.60, compared with 62.90 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Domtar Corporation (UFS) - free report >>

SYNNEX Corporation (SNX) - free report >>

DXC Technology Company. (DXC) - free report >>

More from Zacks Zacks #1 Rank Additions

You May Like